{
    "pmcid": "9859041",
    "qa_pairs": {
        "How does the specialized AlphaFold pipeline ('AF_TCR') improve predictions for TCR:pMHC interactions?": [
            "By using hybrid structural templates to improve prediction accuracy.",
            "By incorporating real-time data from laboratory experiments.",
            "By utilizing a larger dataset of known TCR:pMHC structures.",
            "By applying machine learning algorithms to refine predictions."
        ],
        "What future improvement does the paper suggest for enhancing prediction accuracy?": [
            "Incorporating multiple sequence alignments (MSAs) and exploring other binding affinity estimates.",
            "Increasing the resolution of structural models used in predictions.",
            "Developing new algorithms for faster computational processing.",
            "Integrating data from clinical trials to validate predictions."
        ],
        "What is a key limitation of AlphaFold-Multimer mentioned in the paper?": [
            "It does not perform well on antibody:antigen complexes.",
            "It requires extensive computational resources.",
            "It cannot predict protein folding pathways.",
            "It is not compatible with high-throughput screening methods."
        ],
        "What is the primary focus of the paper regarding TCR:peptide-MHC interactions?": [
            "The use of a specialized version of AlphaFold to predict TCR:peptide-MHC interactions.",
            "The development of new experimental techniques for TCR:peptide-MHC interactions.",
            "The analysis of genetic variations affecting TCR:peptide-MHC interactions.",
            "The study of evolutionary patterns in TCR:peptide-MHC interactions."
        ],
        "What potential application of the study's findings is highlighted for SARS-CoV-2?": [
            "Designing nanobody binders for the SARS-CoV-2 spike protein.",
            "Developing vaccines targeting the SARS-CoV-2 envelope protein.",
            "Creating diagnostic tools for SARS-CoV-2 detection.",
            "Engineering antiviral drugs to inhibit SARS-CoV-2 replication."
        ]
    }
}